- Metabolic Risk Factors Are Associated with the Disease Severity and Prognosis of Hepatitis B Virus-Related Acute on Chronic Liver Failure
-
Chen L, Dai J, Xie Q, Wang X, Cai W
- KMID: 2529853
- Gut Liver.
- 2022 May;16(3):456-464.
- doi: 10.5009/gnl210449
Background/Aims: Metabolic risk factors could accelerate hepatitis B virus (HBV)-related mortality; however, their impacts on disease severity in HBV-related acute on chronic liver failure (HBV-ACLF) patients remain unexplored. In this... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
-
Lee JM, Wei SC, Lee KM, Ye BD, Mao R, Kim HS, Park SJ, Park SH, Oh EH, Im JP, Jang BI, Kim DB, Takeuchi K
- KMID: 2529846
- Gut Liver.
- 2022 May;16(3):396-403.
- doi: 10.5009/gnl210081
Background/Aims: Little is known about the clinical course of hepatitis B virus (HBV)-infected patients undergoing anti-tumor necrosis factor α (TNF-α) therapy for inflammatory bowel disease (IBD). We aimed to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B
-
Hong YM, Yoon KT
- KMID: 2529365
- Korean J Gastroenterol.
- 2022 Apr;79(4):156-160.
- doi: 10.4166/kjg.2022.049
In the natural course of chronic hepatitis B, the immune tolerance phase is characterized by HBeAg positivity, very high levels of HBV DNA, and persistent normal alanine aminotransferase. The international... -
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines for management of chronic hepatitis B
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2528259
- Clin Mol Hepatol.
- 2022 Apr;28(2):276-331.
- doi: 10.3350/cmh.2022.0084
-
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis
-
Jeong J, Shin JW, Jung SW, Park EJ, Park NH
- KMID: 2528254
- Clin Mol Hepatol.
- 2022 Apr;28(2):254-264.
- doi: 10.3350/cmh.2021.0314
Background/Aims: Tenofovir alafenamide (TAF) has shown less favorable effect on lipids compared to tenofovir disoproxil fumarate (TDF) in clinical trials. However, data regarding these outcomes in patients with chronic hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of superb microvascular imaging and shear wave elastography for assessing liver fibrosis in chronic hepatitis B
-
Tosun M, Uslu H
- KMID: 2527441
- Ultrasonography.
- 2022 Apr;41(2):394-402.
- doi: 10.14366/usg.21136
Purpose: The present study investigated the effectiveness and applicability of superb microvascular imaging (SMI) in determining the degree of liver fibrosis noninvasively in comparison with shear wave elastography (SWE). Methods: Ninety-eight... -
- CITED
-
- Close
- SHARE
-
- Close
- A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients
-
Kim HJ, Kim JH, Yeon JE, Seo YS, Jang JW, Cho YK, Jang BK, Han BH, Lee C, Lee JH, Yoon JH, Kim KM, Kim MY, Kim DY, Park NH, Cho EY, Lee JS, Lee JW, Kim IH, Song BC, Lee BS, Kwon OS
- KMID: 2527452
- J Korean Med Sci.
- 2022 Mar;37(11):e92.
- doi: 10.3346/jkms.2022.37.e92
Background: Tenofovir disoproxil fumarate (TDF, Viread® ) had been used as a standard treatment option of chronic hepatitis B (CHB). This clinical trial was conducted to evaluate the efficacy and... -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of key genes and carcinogenic pathways in hepatitis B virus-associated hepatocellular carcinoma through bioinformatics analysis
-
Kim SH, Hwang S, Song GW, Jung DH, Moon DB, Yang JD, Yu HC
- KMID: 2526833
- Ann Hepatobiliary Pancreat Surg.
- 2022 Feb;26(1):58-68.
- doi: 10.14701/ahbps.21-108
Backgrounds/Aims: Mechanisms for the development of hepatocellular carcinoma (HCC) in hepatitis B virus (HBV)-infected patients remain unclear. The aim of the present study was to identify genes and pathways involved... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Effect of Hepatitis B Virus on COVID-19 Infected Patients: A Nationwide Population-Based Study Using the Health Insurance Review & Assessment Service Database
-
Choe JW, Jung YK, Yim HJ, Seo GH
- KMID: 2525010
- J Korean Med Sci.
- 2022 Jan;37(4):e29.
- doi: 10.3346/jkms.2022.37.e29
Background: Several studies have recently suggested that liver disease and cirrhosis were risk factors for poor outcomes in patients with coronavirus disease 2019 (COVID-19) infections. However, no large data study has... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular carcinoma and cancer-related mortality after kidney transplantation with rituximab treatment
-
Lee H, Kim YH, Lim SJ, Ko Y, Shin S, Jung JH, Baek C, Kim H, Park SK, Kwon H
- KMID: 2523770
- Ann Surg Treat Res.
- 2022 Jan;102(1):55-63.
- doi: 10.4174/astr.2022.102.1.55
Purpose: There are increased therapeutic usages of rituximab in kidney transplantation (KT). However, few studies have evaluated the effect of rituximab on cancer development following KT. This study aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
-
Lin H, Wong GLH, Zhang X, Yip TCF, Liu K, Tse YK, Hui VWK, Lai JCT, Chan HLY, Wong VWS
- KMID: 2523873
- Clin Mol Hepatol.
- 2022 Jan;28(1):77-90.
- doi: 10.3350/cmh.2021.0188
Background/Aims: We aimed to determine the association between blood urea level and incident cirrhosis, hepatic decompensation, and hepatocellular carcinoma in chronic liver disease (CLD) patients. Methods: The association between blood urea... -
- CITED
-
- Close
- SHARE
-
- Close
- Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
-
Kim SW, Yoon JS, Lee M, Cho Y
- KMID: 2523867
- Clin Mol Hepatol.
- 2022 Jan;28(1):17-30.
- doi: 10.3350/cmh.2021.0093
Hepatitis B virus (HBV) affects approximately 250 million patients worldwide, resulting in the progression to cirrhosis and hepatocellular carcinoma, which are serious public health problems. Although universal vaccination programs exist,... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver-to-Spleen Volume Ratio Automatically Measured on CT Predicts Decompensation in Patients with B Viral Compensated Cirrhosis
-
Kwon JH, Lee SS, Yoon JS, Suk HI, Sung YS, Kim HS, Lee Cm, Kim KM, Lee SJ, Kim SY
- KMID: 2522934
- Korean J Radiol.
- 2021 Dec;22(12):1985-1995.
- doi: 10.3348/kjr.2021.0348
Objective: Although the liver-to-spleen volume ratio (LSVR) based on CT reflects portal hypertension, its prognostic role in cirrhotic patients has not been proven. We evaluated the utility of LSVR, automatically... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Immunological Factors Associated with Postpartum Hepatic Flares in Immune-Tolerant Pregnant Women with Hepatitis B Virus Infection Treated with Telbivudine
-
Lu J, Wang X, Zhu Y, Ma L, Zheng S, Hu Z, Chen X
- KMID: 2522350
- Gut Liver.
- 2021 Nov;15(6):887-894.
- doi: 10.5009/gnl21001
Background/Aims: To investigate postpartum hepatic flares and associated factors in highly viremic pregnant patients in the immune tolerance phase who adopted telbivudine (LdT) treatment in the last trimester to reduce... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation
-
- KMID: 2522157
- Immune Netw.
- 2021 Oct;21(5):e37.
- doi: 10.4110/in.2021.21.e37
Hepatitis B virus X (HBx) protein has been reported as a key protein regulating the pathogenesis of HBV-induced hepatocellular carcinoma (HCC). Recent evidence has shown that HBx is implicated in... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation
-
- KMID: 2522156
- Immune Netw.
- 2021 Oct;21(5):e37.
- doi: 10.4110/in.2021.21.e37
Hepatitis B virus X (HBx) protein has been reported as a key protein regulating the pathogenesis of HBV-induced hepatocellular carcinoma (HCC). Recent evidence has shown that HBx is implicated in... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation
-
Son J, Kim MJ, Lee JS, Kim JY, Chun E, Lee KY
- KMID: 2522155
- Immune Netw.
- 2021 Oct;21(5):e37.
- doi: 10.4110/in.2021.21.e37
Hepatitis B virus X (HBx) protein has been reported as a key protein regulating the pathogenesis of HBV-induced hepatocellular carcinoma (HCC). Recent evidence has shown that HBx is implicated in... -
- CITED
-
- Close
- SHARE
-
- Close
- History and future of hepatitis B virus control in South Korea
-
Kim DY
- KMID: 2520845
- Clin Mol Hepatol.
- 2021 Oct;27(4):620-622.
- doi: 10.3350/cmh.2021.0277
-
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
-
Kim KD, Lee JE, Kim JM, Lee O, Hwang NY, Rhu J, Choi GS, Kim K, Joh JW
- KMID: 2520843
- Clin Mol Hepatol.
- 2021 Oct;27(4):603-615.
- doi: 10.3350/cmh.2021.0137
Background/Aims: Hepatitis B core antibody (anti-HBc)-positive donors are used as an extended donor pool, and current guidelines recommend the usage of nucleos(t)ide analogues (NAs) as prophylaxis for preventing de novo... -
- CITED
-
- Close
- SHARE
-
- Close
- Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
-
Wu JW, Kao JH, Tseng TC
- KMID: 2520835
- Clin Mol Hepatol.
- 2021 Oct;27(4):524-534.
- doi: 10.3350/cmh.2021.0012
Patients with chronic hepatitis B virus (HBV) infection are at risk of developing hepatocellular carcinoma (HCC), and serum markers reflecting viral replication are potential predictors for HCC development. Besides the... -
- CITED
-
- Close
- SHARE
-
- Close
